Case Report of a DDX41 Germline Mutation in a Family with Multiple Relatives Suffering from Leukemia

被引:0
作者
Wagner, Jan Nicolai [1 ]
Al-Bazaz, Maximilian [1 ]
Forstreuter, Anika [1 ]
Hammada, Mohammad Ibrahim [1 ]
Hille, Jurek [1 ]
Papingi, Dzhoy [2 ]
Bokemeyer, Carsten [1 ]
Fiedler, Walter [1 ]
机构
[1] Univ Med Ctr Hamburg Eppendorf, Dept Oncol Hematol & Bone Marrow Transplantat, Div Pneumol, D-20246 Hamburg, Germany
[2] Univ Med Ctr Hamburg Eppendorf, Inst Human Genet, D-20246 Hamburg, Germany
关键词
acute leukemia; DDX41; germline mutation; CPX-351; genetics; ACUTE MYELOID-LEUKEMIA; LANDSCAPE; VARIANTS; COHORT;
D O I
10.3390/biomedicines12010064
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Introduction: Previously, it was assumed that genetic influence played a minor role in acute myeloid leukemia (AML). Increasing evidence of germline mutations has emerged, such as DDX41 germline mutation associated with familial AML. Case presentation: A 64-year-old male patient presented with reduced exercise tolerance and shortness of breath. Following confirmation of AML diagnosis, the patient was enrolled into the AMLSG-30-18 study with a requirement for allogenic stem cell transplantation. The sister was initially selected as a fully HLA-matched donor. However, the family history showed risks for familial AML. Due to the striking family history, further diagnostic steps were initiated to detect a germline mutation. Methods: Using NGS in the patients' bone marrow AML sample, a DDX41 mutation with a VAF of 49% was detected, raising the possibility of a germline mutation. DNA from cheek swabs and eyebrows were tested for the presence of the DDX41 mutation in all siblings. Results: DDX41 germline mutation was detected in 5 out of 6 siblings. The sister was excluded as a related donor and the search for an unrelated donor was initiated. Conclusion: Obtaining family history of cancer patients plays a crucial role in oncology. If a germline mutation is suspected, further family work-up should be initiated.
引用
收藏
页数:10
相关论文
共 37 条
  • [1] Successful lenalidomide treatment in high risk myelodysplastic syndrome with germline DDX41 mutation
    Abou Dalle, Iman
    Kantarjian, Hagop
    Bannon, Sarah A.
    Kanagal-Shamanna, Rashmi
    Routbort, Mark
    Patel, Keyur P.
    Hu, Shimin
    Bhalla, Kapil
    Garcia-Manero, Guillermo
    DiNardo, Courtney D.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (02) : 227 - 229
  • [2] Nordic Guidelines for Germline Predisposition to Myeloid Neoplasms in Adults: Recommendations for Genetic Diagnosis, Clinical Management and Follow-up
    Baliakas, Panagiotis
    Tesi, Bianca
    Wartiovaara-Kautto, Ulla
    Stray-Pedersen, Asbjorg
    Friis, Lone Smidstrup
    Dybedal, Ingunn
    Hovland, Randi
    Jahnukainen, Kirsi
    Raaschou-Jensen, Klas
    Ljungman, Per
    Rustad, Cecilie F.
    Lautrup, Charlotte K.
    Kilpivaara, Outi
    Kittang, Astrid Olsnes
    Gronbaek, Kirsten
    Cammenga, Jorg
    Hellstrom-Lindberg, Eva
    Andersen, Mette K.
    [J]. HEMASPHERE, 2019, 3 (06):
  • [3] Next-Generation Sequencing of DDX41 in Myeloid Neoplasms Leads to Increased Detection of Germline Alterations
    Bannon, Sarah A.
    Routbort, Mark J.
    Montalban-Bravo, Guillermo
    Mehta, Rohtesh S.
    Jelloul, Fatima Zahra
    Takahashi, Koichi
    Daver, Naval
    Oran, Betul
    Pemmaraju, Naveen
    Borthakur, Gautam
    Naqvi, Kiran
    Issa, Ghayas
    Sasaki, Koji
    Alvarado, Yesid
    Kadia, Tapan M.
    Konopleva, Marina
    Shamanna, Rashmi Kanagal
    Khoury, Joseph D.
    Ravandi, Farhad
    Champlin, Richard
    Kantarjian, Hagop M.
    Bhalla, Kapil
    Garcia-Manero, Guillermo
    Patel, Keyur P.
    DiNardo, Courtney D.
    [J]. FRONTIERS IN ONCOLOGY, 2021, 10
  • [4] Re-emergence of acute myeloid leukemia in donor cells following allogeneic transplantation in a family with a germline DDX41 mutation
    Berger, G.
    van den Berg, E.
    Sikkema-Raddatz, B.
    Abbott, K. M.
    Sinke, R. J.
    Bungener, L. B.
    Mulder, A. B.
    Vellenga, E.
    [J]. LEUKEMIA, 2017, 31 (02) : 520 - 522
  • [5] A landscape of germ line mutations in a cohort of inherited bone marrow failure patients
    Bluteau, Olivier
    Sebert, Marie
    Leblanc, Thierry
    de latour, Regis Peffault
    Quentin, Samuel
    Lainey, Elodie
    Hernandez, Lucie
    Dalle, Jean-Hugues
    de Fontbrune, Flore Sicre
    Lengline, Etienne
    Itzykson, Raphael
    Clappier, Emmanuelle
    Boissel, Nicolas
    Vasquez, Nadia
    Da Costa, Melanie
    Masliah-Planchon, Julien
    Cuccuini, Wendy
    Raimbault, Anna
    De Jaegere, Louis
    Ades, Lionel
    Fenaux, Pierre
    Maury, Sebastien
    Schmitt, Claudine
    Muller, Marc
    Domenech, Carine
    Blin, Nicolas
    Bruno, Benedicte
    Pellier, Isabelle
    Hunault, Mathilde
    Blanche, Stephane
    Petit, Arnaud
    Leverger, Guy
    Michel, Gerard
    Bertrand, Yves
    Baruchel, Andre
    Socie, Gerard
    Soulier, Jean
    [J]. BLOOD, 2018, 131 (07) : 717 - 732
  • [6] Unique ethnic features of DDX41 mutations in patients with idiopathic cytopenia of undetermined significance, myelodysplastic syndrome, or acute myeloid leukemia
    Choi, Eun-Ji
    Cho, Young-Uk
    Hur, Eun-Hye
    Jang, Seongsoo
    Kim, Nayoung
    Park, Han-Seung
    Lee, Jung-Hee
    Lee, Kyoo-Hyung
    Kim, Si-Hwan
    Hwang, Sang-Hyun
    Seo, Eul-Ju
    Park, Chan-Jeoung
    Lee, Je-Hwan
    [J]. HAEMATOLOGICA, 2022, 107 (02) : 510 - 518
  • [7] When Should Tumor Genomic Profiling Prompt Consideration of Germline Testing?
    DeLeonardis, Kim
    Hogan, Lauren
    Cannistra, Stephen A.
    Rangachari, Deepa
    Tung, Nadine
    [J]. JOURNAL OF ONCOLOGY PRACTICE, 2019, 15 (09) : 465 - +
  • [8] Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
    Doehner, Hartmut
    Wei, Andrew H.
    Appelbaum, Frederick R.
    Craddock, Charles
    DiNardo, Courtney D.
    Dombret, Herve
    Ebert, Benjamin L.
    Fenaux, Pierre
    Godley, Lucy A.
    Hasserjian, Robert P.
    Larson, Richard A.
    Levine, Ross L.
    Miyazaki, Yasushi
    Niederwieser, Dietger
    Ossenkoppele, Gert
    Roellig, Christoph
    Sierra, Jorge
    Stein, Eytan M.
    Tallman, Martin S.
    Tien, Hwei-Fang
    Wang, Jianxiang
    Wierzbowska, Agnieszka
    Lowenberg, Bob
    [J]. BLOOD, 2022, 140 (12) : 1345 - 1377
  • [9] How I diagnose and manage individuals at risk for inherited myeloid malignancies
    Drazer, Michael W.
    Feurstein, Simone
    West, Allison H.
    Jones, Matthew F.
    Churpek, Jane E.
    Godley, Lucy A.
    [J]. BLOOD, 2016, 128 (14) : 1800 - 1813
  • [10] Prognostic impact of DDX41 germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO study
    Duployez, Nicolas
    Largeaud, Laetitia
    Duchmann, Matthieu
    Kim, Rathana
    Rieunier, Julie
    Lambert, Juliette
    Bidet, Audrey
    Larcher, Lise
    Lemoine, Jean
    Delhommeau, Francois
    Hirsch, Pierre
    Fenwarth, Laurene
    Kosmider, Olivier
    Decroocq, Justine
    Bouvier, Anne
    Le Bris, Yannick
    Ochmann, Marlene
    Santagostino, Alberto
    Ades, Lionel
    Fenaux, Pierre
    Thomas, Xavier
    Micol, Jean-Baptiste
    Gardin, Claude
    Itzykson, Raphael
    Soulier, Jean
    Clappier, Emmanuelle
    Recher, Christian
    Preudhomme, Claude
    Pigneux, Arnaud
    Dombret, Herve
    Delabesse, Eric
    Sebert, Marie
    [J]. BLOOD, 2022, 140 (07) : 756 - 768